An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users administering products of uncertain source.
Some professionals said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the platform has removed violative material and prohibited related keywords and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered communities with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for mixing or administering at home.
After moments of joining one group, a vendor posted contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Costs
Within these communities, posts show black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how long a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they cannot confirm. Even if the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has previously seen patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.
